Sberbank has created a manufacturer of medicines
Sberbank has founded the Immunotechnologies company, whose main activities will be wholesale trade of pharmaceutical products, production of pharmaceutical substances, medicines, as well as research and development in the field of biotechnology. The company was registered on may 15, 100% of it belongs to Sberbank, the authorized capital is 50 million rubles, Vedomosti writes.
Dmitry Efimov, former CEO of nizhpharma and senior Vice President of Stada CIS, has been appointed CEO of the company. Now, according to SPARK, he is on the boards of Directors of the V. I. Lenin medical Instrument plant in Nizhny Novgorod and the Nizhny Novgorod pharmacy chain.
Sberbank also offered its employees to become volunteers in testing the coronavirus vaccine. This was reported by the media with reference to a copy of the letter received by the Bank's employees. It listed requirements for volunteers and contraindications to participating in the program.